⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27869082 | 1.00 | — | — | |
| SCHEMBL309720 | 1.00 | — | — | |
| SCHEMBL19248370 | 0.89 | ALDH1A1 (0.42) | — | |
| SCHEMBL15542043 | 0.89 | ALDH1A1 (0.42) | — | |
| SCHEMBL12122472 | 0.89 | ALDH1A1 (0.42) | — | |
| SCHEMBL25342022 | 0.89 | ALDH1A1 (0.42) | — | |
| SCHEMBL29211194 | 0.88 | MAPT (0.41) | — | |
| SCHEMBL9756912 | 0.87 | TDP1 (0.48) | — | |
| SCHEMBL26133678 | 0.86 | ALOX15 (0.46) | — | |
| SCHEMBL30173470 | 0.84 | MAPT (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217091-A1 | ODORANTS FOR FLUIDS, ODORIZED FLUIDS, METHODS, AND SYSTEMS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025217099-A1 | INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-117330692-B | Method for analyzing liquorice polysaccharide based on UPLC-Q-TOF-MS/MS technology | 康奇(天津)生物技术股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117330692-A | Method for analyzing liquorice polysaccharide based on UPLC-Q-TOF-MS/MS technology | 康奇(天津)生物技术股份有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-116298043-A | Screening method of inonotus obliquus active action quality markers and construction and application of chemical characterization map thereof | 哈尔滨商业大学 | 2023-06-23 | — | — | CN | disclosed |
| EP-4128392-A1 | LITHIUM-ION BATTERY WITH ANODE COMPRISING BLEND OF INTERCALATION-TYPE ANODE MATERIAL AND CONVERSION-TYPE ANODE MATERIAL | Sila Nanotechnologies Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| US-8664189-B2 | RNA interference in skin indications | RXI PHARMACEUTICALS CORPORATION (US) | 2014-03-04 | — | — | US | disclosed |
| US-8039465-B2 | Cytoskeletal active compounds, composition and use | INSPIRE PHARMACEUTICALS, INC. (US) | 2011-10-18 | — | — | US | disclosed |
| US-20110165084-A1 | VIVO DETECTION OF PHOSPHOLIPASE ACTIVATION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-07-07 | — | — | US | disclosed |
| US-20100130572-A1 | CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE | LAMPE JOHN W | 2010-05-27 | — | — | US | disclosed |
| US-7666861-B2 | Cytoskeletal active compounds, composition and use | INSPIRE PHARMACEUTICALS, INC. (US) | 2010-02-23 | — | — | US | disclosed |
| US-20090312326-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| US-7592362-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-09-22 | — | — | US | disclosed |
| US-7547718-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-16 | — | — | US | disclosed |
| US-7544706-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-09 | — | — | US | disclosed |
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-22 | — | — | US | disclosed |
| US-20080076735-A1 | CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE | CHATTEM INC. | 2008-03-27 | — | — | US | disclosed |
| US-20070167506-A1 | SUBSTITUTED IMIDAZOLES | PFIZER INC. (US) | 2007-07-19 | — | — | US | disclosed |